Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/65199| metadata.dc.identifier.doi: | https://doi.org/10.56042/ijbb.v62i2.13682 |
| Title: | In silico molecular docking and virtual screening of natural compounds against Tubulin-7-Aminonoscapine complex (6Y6D) for estimation of anticancer potential |
| Authors: | Kashid, Snehal Shinde, Prashali Pawar, Reshma Mishra, Ashish |
| Keywords: | Anticancer;Autodock vina;Molecular docking;PDB ID:6Y6D;Phytoconstituents |
| Issue Date: | Jan-2025 |
| Publisher: | NIScPR-CSIR, India |
| Abstract: | This comprehensive study integrated in silico molecular docking and pharmacokinetic profiling to elucidate the interactions and properties of eight bioactive compounds (nimbin, azadirachtin, betasitosterol, nimbidinin, chavicol, chavibetol, curcumin, and zingiberene) from natural sources with protein 6Y6D. SwissADME and SwissTargetPrediction are used for pharmacokinetic screening, whereas, autodock vina is used for molecular docking and virtual screening. Protox3 software was used to establish each phytoconstituent's specific toxicity profile. According to the results, nimbidinin and nimbin exhibit extraordinary binding affinity without toxicity and have the potential to be further screened as lead compounds. Azadirachtin, on the other hand, exhibits the highest binding affinity with a moderate toxicity profile. Furthermore, zingiberene and chavicol exhibit low binding affinities. A detailed investigation reveals the binding modes and molecular interactions with different amino acids. Our findings may facilitate the development of novel drugs and provide a foundation for further experimental validation. |
| Page(s): | 117-130 |
| ISSN: | 0975-0959 (Online), 0301-1208 (Print) |
| Appears in Collections: | IJBB Vol.62(02) [February 2025] IJBB Vol.62(02) [February 2025] |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJBB Vol.62(2)117-130.pdf | 2.03 MB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.